Furosemide
- Product NDC
- 43353-069
- 11-digit product format
- 433530069
- Labeler code
- 43353
- Product ID
- 43353-069_13d5f0a8-f822-4190-99b3-32f2a1126caf
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Furosemide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- NDA018823
- Marketing category
- NDA
- Marketing start
- 1983-11-10
- Substance
- FUROSEMIDE
- Active strength
- 40 mg/1
- Pharmacologic classes
- Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Furosemide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| FUROSEMIDE | 40 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 7LXU5N7ZO5 |
| Rxcui | 310429, 313988 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 43353-069-30 | Furosemide | 30 in 1 BOTTLE | TABLET | 30 | | 4 |
| 43353-069-45 | Furosemide | 45 in 1 BOTTLE | TABLET | 45 | | 4 |
| 43353-069-53 | Furosemide | 60 in 1 BOTTLE | TABLET | 60 | | 4 |
| 43353-069-60 | Furosemide | 90 in 1 BOTTLE | TABLET | 90 | | 4 |
| 43353-069-80 | Furosemide | 180 in 1 BOTTLE | TABLET | 180 | | 4 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| FUROSEMIDE | ACTIVE INGREDIENT | 7LXU5N7ZO5 | FUROSEMIDE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 2 | |
| FUROSEMIDE | ACTIVE MOIETY | 7LXU5N7ZO5 | FUROSEMIDE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | FUROSEMIDE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 2 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | FUROSEMIDE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 2 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | FUROSEMIDE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 2 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | FUROSEMIDE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 2 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | FUROSEMIDE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 2 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | FUROSEMIDE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 2 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | FUROSEMIDE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 2 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43353-069 | FUROSEMIDE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 4 | Current NDC, Legacy NDC, 5 package rows | 20180213_6fbf7f3d-7566-44d5-9507-c4460238fc91.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43353-069-30 | 43353006930 | 30 TABLET in 1 BOTTLE (43353-069-30) | 30 tablet | 2017-06-19 | 0000-00-00 | No | No | Current |
| 43353-069-45 | 43353006945 | 45 TABLET in 1 BOTTLE (43353-069-45) | 45 tablet | 2017-06-19 | 0000-00-00 | No | No | Current |
| 43353-069-53 | 43353006953 | 60 TABLET in 1 BOTTLE (43353-069-53) | 60 tablet | 2017-06-19 | 0000-00-00 | No | No | Current |
| 43353-069-60 | 43353006960 | 90 TABLET in 1 BOTTLE (43353-069-60) | 90 tablet | 2017-06-19 | 0000-00-00 | No | No | Current |
| 43353-069-80 | 43353006980 | 180 TABLET in 1 BOTTLE (43353-069-80) | 180 tablet | 2017-06-19 | 0000-00-00 | No | No | Current |